| Aug 8 |
PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
|
| Aug 7 |
PTC Therapeutics Q2 2024 Earnings Preview
|
| Aug 6 |
Unlocking Q2 Potential of PTC Therapeutics (PTCT): Exploring Wall Street Estimates for Key Metrics
|
| Aug 1 |
Crinetics Pharmaceuticals, Inc. (CRNX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
| Jul 30 |
PTC Therapeutics Announces Sepiapterin NDA Submission to FDA
|
| Jul 25 |
PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2024 Financial Results
|
| Jul 25 |
Will PTC Therapeutics (PTCT) Report Negative Q2 Earnings? What You Should Know
|
| Jul 1 |
PTC Therapeutics (PTCT) Down on Negative CHMP Opinion on DMD Drug
|
| Jun 28 |
Biggest stock movers today: PLUG, NKE, DJT, and more
|
| Jun 28 |
PTC Therapeutics Tumbles After European Regulators Reject Its Drug — Again
|
